- Lobbying
- Lobbying by PATH Decision Support Software, LLC
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Philip Cronin | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Veterans Affairs - Dept of (VA)
Natl Science Foundation (NSF)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Natl Science Foundation (NSF)
Veterans Affairs - Dept of (VA)
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Veterans Affairs - Dept of (VA)
Natl Science Foundation (NSF)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Natl Science Foundation (NSF)
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Veterans Affairs - Dept of (VA)
Natl Science Foundation (NSF)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Natl Science Foundation (NSF)
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Veterans Affairs - Dept of (VA)
Natl Science Foundation (NSF)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Natl Science Foundation (NSF)
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Veterans Affairs - Dept of (VA)
Natl Science Foundation (NSF)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Natl Science Foundation (NSF)
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Indian Health Service
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Indian Health Service
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Medicare and Medicaid Services (CMS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: 21st Century Cures
Issues and legislation related to diabetes.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate